Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
The neuropsychology of schizophrenia
Gray, J. A., Feldon, J., Rawlins, J. N. P., Hemsley, D. R., & Smith, A. D. (1991) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00065055 · Cited by 1,350 · cited 2×
“dominant response set, excessive yielding to the immediate situational demands, and enhanced switching from one associative content to another (e.g., Anscombe, 1987; Gray et al., 1991; Lyon, 1991; Magaro, 1980; Swerdlow and Koob, 1987; Weiner and Joel, 2002; Yogev et al., 2003).”
BackgroundMaternal influenza infection causes marked behavioral and pharmacological changes in the offspring
Shi, L., Fatemi, S. H., Sidwell, R. W., & Patterson, P. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00297.2003 · Cited by 1,025 · cited 1×
“, 2003), as well as by a recent report that prenatal poly I:C administration led to an additional schizophrenia-like deficit, loss of prepulse inhibition, in mice (Shi et al., 2003).”
BackgroundBayer, S. A. (1980) · Journal of Comparative Neurology · doi:10.1002/cne.901900107 · Cited by 912
Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence
Arnt, J. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00112-7 · Cited by 715
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
Differential Performance of Acute and Chronic Schizophrenics in a Latent Inhibition Task
BARUCH, I., HEMSLEY, D. R., & GRAY, J. A. (1988) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198810000-00004 · Cited by 606
The Left Striato-pallidal Hyperactivity Model of Schizophrenia
Early, T. S., Haller, J. W., Posner, M. I., & Raichle, M. (2019) · The Neuropsychology of Schizophrenia · doi:10.4324/9781315785004-2 · Cited by 598
From neuropathology to neurodevelopment
Weinberger, D. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91386-6 · Cited by 565
Carboni, E., Imperato, A., Perezzani, L., & Di Chiara, G. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90012-2 · Cited by 561
Zuckerman, L., Rehavi, M., Nachman, R., & Weiner, I. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300248 · Cited by 485
Self-citationThe NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
Carlsson, M., & Carlsson, A. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258633 · Cited by 423
Bringing Order to the Glutamate Chaos in Schizophrenia
Moghaddam, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00757-8 · Cited by 403
Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1313-x · Cited by 391
Self-citationSchizophrenia and Glutamatergic Transmission
Tamminga, C. A. (1998) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v12.i1-2.20 · Cited by 385
Borrell, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00360-8 · Cited by 307
The role of noradrenaline in tuning and dopamine in switching between signals in the CNS
Oades, R. D. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90050-8 · Cited by 306
Prenatal rubella, premorbid abnormalities, and adult schizophrenia
Brown, A. S., Cohen, P., Harkavy-Friedman, J., Babulas, V., Malaspina, D., Gorman, J. M., & Susser, E. S. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01068-x · Cited by 299
Neurotransmitter interactions in schizophrenia–therapeutic implications
Carlsson, A., Waters, N., & Carlsson, M. L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00117-1 · Cited by 298
Disruption of latent inhibition by acute administration of low doses of amphetamine
Weiner, I., Lubow, R. E., & Feldon, J. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90113-x · Cited by 286
Self-citationRecent Advances in the Neuropathology of Schizophrenia
Bogerts, B. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.431 · Cited by 283
Fatemi, S. H., Emamian, E. S., Kist, D., Sidwell, R. W., Nakajima, K., Akhter, P., Shier, A., Sheikh, S., & Bailey, K. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000520 · Cited by 262
Weiner, I., Lubow, R. E., & Feldon, J. (1984) · Psychopharmacology · doi:10.1007/bf00429734 · Cited by 262
Self-citationAbolition of latent inhibition by a single 5 mg dose ofd-amphetamine in man
Gray, N. S., Pickering, A. D., Hemsley, D. R., Dawling, S., & Gray, J. A. (1992) · Psychopharmacology · doi:10.1007/bf02245170 · Cited by 261
Abolition of latent inhibition in acute, but not chronic, schizophrenics
Gray, N. S. (1992) · Neurology Psychiatry and Brain Research · Cited by 259
The pharmacology of latent inhibition as an animal model of schizophrenia
Moser, P. C., Hitchcock, J. M., Lister, S., & Moran, P. M. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00026-6 · Cited by 247
The Disorder of Consciousness in Schizophrenia
Anscombe, R. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.241 · Cited by 225
Watson, C. G. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790120089011 · Cited by 217
Martin, G. F. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90080-o · Cited by 216
Muscimol Inactivation of the Dorsal Hippocampus Impairs Contextual Retrieval of Fear Memory
Holt, W., & Maren, S. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-09054.1999 · Cited by 214
Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia
GILMORE, J., & FREDRIKJARSKOG, L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00123-5 · Cited by 209
The NMDA Antagonist Model for Schizophrenia: Promise and Pitfalls
Abi-Saab, W., D'Souza, D., Moghaddam, B., & Krystal, J. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979354 · Cited by 208
Adams, W., Kendell, R. E., Hare, E. H., & Munk-Jørgensen, P. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.163.4.522 · Cited by 204
Chronic amphetamine and latent inhibition
Weiner, I., Lubow, R. E., & Feldon, J. (1981) · Behavioural Brain Research · doi:10.1016/0166-4328(81)90105-4 · Cited by 193
Self-citationCytokine and growth factor involvement in schizophrenia—support for the developmental model
Nawa, H., Takahashi, M., & Patterson, P. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000730 · Cited by 191
Schizophrenic births and viral diseases in two states
Fuller Torrey, E., Rawlings, R., & Waldman, I. N. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90043-6 · Cited by 184
Cognition in schizophrenia and paranoia : the integration of cognitive processes
Magaro, P. A. (1980) · Lawrence Erlbaum Associates eBooks · Cited by 182
Infection and Autoimmunity as Etiologic Factors in Schizophrenia: A Review and Reappraisal
Kirch, D. G. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.355 · Cited by 176
Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms
Pearce, B. D. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000956 · Cited by 171
Effects of nicotine and amphetamine on latent inhibition in human subjects
Thornton, J. C., Dawe, S., Lee, C., Capstick, C., Corr, P. J., Cotter, P., Frangou, S., Gray, N. S., Russell, M. A. H., & Gray, J. A. (1996) · Psychopharmacology · doi:10.1007/bf02805990 · Cited by 160
Clinical features of latent inhibition in schizophrenia
Rascle, C., Mazas, O., Vaïva, G., Tournant, M., Raybois, O., Goudemand, M., & Thomas, P. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00162-6 · Cited by 157
Miller, D. W., & Abercrombie, E. D. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02144-2 · Cited by 155
Non-competitive antagonists are potent activators of ventral tegmental A10 dopamine neurons
French, E. D., & Ceci, A. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90823-r · Cited by 152
Cell migration in the rat embryonic neocortex
Bayer, S. A., Altman, J., Russo, R. J., Dai, X., & Simmons, J. A. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903070312 · Cited by 147
Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia
Marx, C. E., Jarskog, L. F., Lauder, J. M., Lieberman, J. A., & Gilmore, J. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01209-4 · Cited by 145
Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation
Zuckerman, L., & Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1461-7 · Cited by 138
Self-citationYee, B. K., Feldon, J., & Rawlins, J. N. P. (1995) · Behavioral Neuroscience · doi:10.1037//0735-7044.109.2.227 · Cited by 127
Katafuchi, T., Kondo, T., Yasaka, T., Kubo, K., Take, S., & Yoshimura, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00365-8 · Cited by 123
Schizophrenia following in utero exposure to the 1957 influenza epidemics in Japan
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.450 · Cited by 119
The Relationship of Schizophrenic Births to 16 Infectious Diseases
O'Callaghan, E., Sham, P. C., Takei, N., Murray, G., Glover, G., Hare, E. H., & Murray, R. M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.165.3.353 · Cited by 110
Weiner, I., Shadach, E., Tarrasch, R., Kidron, R., & Feldon, J. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00573-0 · Cited by 107
Self-citationContextual control over conditioned responding in a latent inhibition paradigm.
Westbrook, R. F., Jones, M. L., Bailey, G. K., & Harris, J. A. (2000) · Journal of Experimental Psychology Animal Behavior Processes · doi:10.1037//0097-7403.26.2.157 · Cited by 106
Entorhinal but Not Hippocampal or Subicular Lesions Disrupt Latent Inhibition in Rats
Coutureau, É., Galani, R., Gosselin, O., Majchrzak, M. J., & Scala, G. D. (1999) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1998.3895 · Cited by 105
Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA
Kimura, M., Toth, L. A., Agostini, H., Cady, A. B., Majde, J. A., & Krueger, J. M. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.267.6.r1596 · Cited by 102
Joseph, M. H., Peters, S. L., Moran, P. M., Grigoryan, G. A., Young, A. M. J., & Gray, J. A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00437-1 · Cited by 101
Contemporary Issues in Modeling Psychopathology
Myslobodsky, M. S. (2000) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-4860-4 · Cited by 92
The involvement of the nucleus accumbens in the ability of rats to switch to cue-directed behaviours
van den Bos, R., & Cools, A. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90486-4 · Cited by 88
Schizophrenia: Genetics and the maternal immune response to viral infection
Wright, P., Gill, M., & Murray, R. M. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480110 · Cited by 86
Rubin, S. A., Sylves, P., Vogel, M., Pletnikov, M., Moran, T. H., Schwartz, G. J., & Carbone, K. M. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00133-6 · Cited by 84
Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses
Vaitl, D., Lipp, O. V., Bauer, U., Schüler, G., Stark, R. M., Zimmermann, M., & Kirsch, P. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00250-x · Cited by 82
Genes, viruses and neurodevelopmental schizophrenia
Murray, R. M., Jones, P. B., O’Callaghan, E., Takei, N., & Sham, P. C. (1992) · Journal of Psychiatric Research · doi:10.1016/0022-3956(92)90029-n · Cited by 81
Latent inhibition and autonomic respones: a psychophysiological approach
Vaitl, D., & Lipp, O. V. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)02310-3 · Cited by 75
Schizophrenia and the influenza epidemics of 1957 in Japan
Izumoto, Y., Inoue, S., & Yasuda, N. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00359-x · Cited by 70
Druhan, J. P., Rajabi, H., & Stewart, J. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199610)24:2<135::aid-syn5>3.0.co;2-g · Cited by 69
The Latent Inhibition Model Dissociates between Clozapine, Haloperidol, and Ritanserin
Shadach, E., Gaisler, I., Schiller, D., & Weiner, I. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00096-8 · Cited by 66
Self-citationEffects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat
French, E. D. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90246-7 · Cited by 65
Reversal and nonreversal shifts under amphetamine
Weiner, I., & Feldon, J. (1986) · Psychopharmacology · doi:10.1007/bf00174374 · Cited by 63
Self-citationWeiner, I., Shadach, E., Barkai, R., & Feldon, J. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00145-5 · Cited by 62
Self-citationWeiner, I., Feldon, J., & Ben‐Shahar, O. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90066-3 · Cited by 54
Self-citationPolyinosinic:polycytidylic acid is a potent activator of endothelial cells.
Doukas, J., Cutler, A. H., & Mordes, J. P. (1994) · PubMed Central · Cited by 53
Context-specific interference on reversal learning of a stimulus-response habit
McDonald, R. J., King, A. L., & Hong, N. S. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00160-7 · Cited by 51
Amphetamine and the overtraining reversal effect
Weiner, I., Ben-Horin, E., & Feldon, J. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90481-8 · Cited by 49
Self-citationInterferon production by cultured human trophoblast induced with double stranded polyribonucleotide
Tóth, F., Juhl, C. B., Nørskov‐Lauritsen, N., Petersen, P. M., & Ebbesen, P. (1990) · Journal of Reproductive Immunology · doi:10.1016/0165-0378(90)90004-p · Cited by 49
Pruett, S. B., Fan, R., & Zheng, Q. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02507-9 · Cited by 48
Engel, J., Zhang, J., Bergström, T. B., CONRADI, N. G., Forkstam, C., Liljeroth, A., & Svensson, L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02149-1 · Cited by 48
Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages
Snell, J. C., Chernyshev, O., Gilbert, D. L., & Colton, C. A. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.3.369 · Cited by 42
Weiner, I., & Joel, D. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06765-9_13 · Cited by 41
Self-citationRothschild, D. M., O'Grady, M., & Wecker, L. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990815)57:4<429::aid-jnr2>3.0.co;2-d · Cited by 40
Shadach, E., Feldon, J., & Weiner, I. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001583 · Cited by 39
Self-citationTreatment of negative and cognitive symptoms
Javitt, D. C. (1999) · Current Psychiatry Reports · doi:10.1007/s11920-999-0007-z · Cited by 38
Developmental malformations in cerebral structures of schizophrenic patients
Beckmann, H. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014184 · Cited by 37
Perseveration and over-switching in schizophrenia
Yogev, H., Hadar, U., Gutman, Y., & Sirota, P. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00323-7 · Cited by 37
Viral infection of developing GABAergic neurons in a model of hippocampal disinhibition
Pearce, B. D., Valadi, N. M., Po, C. L., & Miller, A. H. (2000) · NeuroReport · doi:10.1097/00001756-200008030-00019 · Cited by 37
Immunopathology and Viral Reactivation
Waltrip, R. W., Carrigan, D. R., & Carpenter, W. T. (1990) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199012000-00001 · Cited by 35
The Latent Inhibition Model of Schizophrenia
Weiner, I. (2000) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-4860-4_12 · Cited by 27
Self-citationCoutureau, É., Léna, I., Daugé, V., & Scala, G. D. (2002) · Behavioral Neuroscience · doi:10.1037//0735-7044.116.1.95 · Cited by 26
Coutureau, É., Gosselin, O., & Scala, G. D. (2000) · Psychopharmacology · doi:10.1007/s002130000434 · Cited by 22
Yee, B. K., & Rawlins, J. N. P. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00163-0 · Cited by 22
Gelissen, M., & Cools, A. R. (1988) · Behavioural Brain Research · doi:10.1016/0166-4328(88)90048-4 · Cited by 16
Viral Mechanisms of Schizophrenia
Pearce, B. D. (2000) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-4860-4_6 · Cited by 7
Cited by
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
Immune involvement in schizophrenia and autism: Etiology, pathology and animal models
Patterson, P. H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.016 · Cited by 766
The environment and susceptibility to schizophrenia
Brown, A. S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.003 · Cited by 664
Early-life programming of later-life brain and behavior: a critical role for the immune system
Bilbo, S. D. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.014.2009 · Cited by 652
Metadata
- Authors
- Zuckerman, L., & Weiner, I.
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 39
- Issue
- 3
- Pages
- 311-323
- ISSN
- 0022-3956 (ISSN-L)
- OpenAlex
- W2033880528
- Cited by
- 352
- References
- 91
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.